Follow the people · Insider
Kathleen Goin
Kathleen Goin files insider transactions with the SEC as a chief operating officer of Palvella Therapeutics (PVLA). We hold 8 disclosed purchases and sales filed since 17 December 2024, 3 of them in the last 90 days.
- Files forPVLA
- Disclosed buys and sells8 in all, 3 in the last 90 days
- Last disclosure20 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 13 December 2024 — 19 August 2026Chief Operating Officer · Palvella Therapeutics (PVLA)94 Form 4 lines · source: SEC Form 4
Everything they disclosed
94 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 420 August 2026Common Stock · traded 19 August 2026 · filed 20 August 2026
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 420 August 2026Common Stock · traded 19 August 2026 · filed 20 August 2026
- ▼ sold on the open market 1,500 shares of Palvella TherapeuticsSEC Form 420 August 2026Common Stock · traded 19 August 2026 · filed 20 August 2026
- ▼ sold on the open market 1,998 shares of Palvella TherapeuticsSEC Form 420 August 2026Common Stock · traded 19 August 2026 · filed 20 August 2026
- ▼ sold on the open market 400 shares of Palvella TherapeuticsSEC Form 420 August 2026Common Stock · traded 19 August 2026 · filed 20 August 2026
- ▼ sold on the open market 102 shares of Palvella TherapeuticsSEC Form 420 August 2026Common Stock · traded 19 August 2026 · filed 20 August 2026
- ▼ sold on the open market 302 shares of Palvella TherapeuticsSEC Form 420 August 2026Common Stock · traded 19 August 2026 · filed 20 August 2026
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 420 August 2026Stock Option (Right to Buy) · traded 19 August 2026 · filed 20 August 2026
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 420 August 2026Stock Option (Right to Buy) · traded 19 August 2026 · filed 20 August 2026
- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 522 shares of Palvella TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 840 shares of Palvella TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 1,029 shares of Palvella TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- ▼ sold on the open market 1,911 shares of Palvella TherapeuticsSEC Form 417 July 2026Common Stock · traded 15 July 2026 · filed 17 July 2026
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 417 July 2026Stock Option (Right to Buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 417 July 2026Stock Option (Right to Buy) · traded 15 July 2026 · filed 17 July 2026
- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 422 June 2026Common Stock · traded 17 June 2026 · filed 22 June 2026
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 422 June 2026Common Stock · traded 17 June 2026 · filed 22 June 2026
- ▼ sold on the open market 2,390 shares of Palvella TherapeuticsSEC Form 422 June 2026Common Stock · traded 17 June 2026 · filed 22 June 2026
- ▼ sold on the open market 1,887 shares of Palvella TherapeuticsSEC Form 422 June 2026Common Stock · traded 17 June 2026 · filed 22 June 2026
- ▼ sold on the open market 25 shares of Palvella TherapeuticsSEC Form 422 June 2026Common Stock · traded 17 June 2026 · filed 22 June 2026
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 422 June 2026Stock Option (Right to Buy) · traded 17 June 2026 · filed 22 June 2026
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 422 June 2026Stock Option (Right to Buy) · traded 17 June 2026 · filed 22 June 2026
- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 422 May 2026Common Stock · traded 20 May 2026 · filed 22 May 2026
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 422 May 2026Common Stock · traded 20 May 2026 · filed 22 May 2026
- ▼ sold on the open market 3,363 shares of Palvella TherapeuticsSEC Form 422 May 2026Common Stock · traded 20 May 2026 · filed 22 May 2026
- ▼ sold on the open market 891 shares of Palvella TherapeuticsSEC Form 422 May 2026Common Stock · traded 20 May 2026 · filed 22 May 2026
- ▼ sold on the open market 48 shares of Palvella TherapeuticsSEC Form 422 May 2026Common Stock · traded 20 May 2026 · filed 22 May 2026
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 422 May 2026Stock Option (Right to Buy) · traded 20 May 2026 · filed 22 May 2026
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 422 May 2026Stock Option (Right to Buy) · traded 20 May 2026 · filed 22 May 2026
- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 1,502 shares of Palvella TherapeuticsSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 1,500 shares of Palvella TherapeuticsSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 561 shares of Palvella TherapeuticsSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 639 shares of Palvella TherapeuticsSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 100 shares of Palvella TherapeuticsSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 417 April 2026Stock Option (Right to Buy) · traded 15 April 2026 · filed 17 April 2026
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 417 April 2026Stock Option (Right to Buy) · traded 15 April 2026 · filed 17 April 2026
- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- ▼ sold on the open market 2,268 shares of Palvella TherapeuticsSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 420 March 2026Stock Option (Right to Buy) · traded 18 March 2026 · filed 20 March 2026
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 420 March 2026Stock Option (Right to Buy) · traded 18 March 2026 · filed 20 March 2026
- ▼ sold on the open market 1,730 shares of Palvella TherapeuticsSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- ▼ sold on the open market 304 shares of Palvella TherapeuticsSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 420 March 2026Stock Option (Right to Buy) · traded 18 March 2026 · filed 20 March 2026
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 420 March 2026Stock Option (Right to Buy) · traded 18 March 2026 · filed 20 March 2026
- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- ▼ sold on the open market 2,268 shares of Palvella TherapeuticsSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- ▼ sold on the open market 1,730 shares of Palvella TherapeuticsSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- ▼ sold on the open market 304 shares of Palvella TherapeuticsSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 3,026 shares of Palvella TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 420 February 2026Stock Option (Right to Buy) · traded 18 February 2026 · filed 20 February 2026
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 420 February 2026Stock Option (Right to Buy) · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 1,276 shares of Palvella TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 420 February 2026Stock Option (Right to Buy) · traded 18 February 2026 · filed 20 February 2026
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 420 February 2026Stock Option (Right to Buy) · traded 18 February 2026 · filed 20 February 2026
- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 3,026 shares of Palvella TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- ▼ sold on the open market 1,276 shares of Palvella TherapeuticsSEC Form 420 February 2026Common Stock · traded 18 February 2026 · filed 20 February 2026
- was granted 48,956 shares of Palvella Therapeutics (a derivative holding)SEC Form 49 February 2026Stock Option (Right to Buy) · traded 5 February 2026 · filed 9 February 2026
- was granted 48,956 shares of Palvella Therapeutics (a derivative holding)SEC Form 49 February 2026Stock Option (Right to Buy) · traded 5 February 2026 · filed 9 February 2026
- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 423 January 2026Common Stock · traded 21 January 2026 · filed 23 January 2026
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 423 January 2026Common Stock · traded 21 January 2026 · filed 23 January 2026
- ▼ sold on the open market 553 shares of Palvella TherapeuticsSEC Form 423 January 2026Common Stock · traded 21 January 2026 · filed 23 January 2026
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 423 January 2026Stock Option (Right to Buy) · traded 21 January 2026 · filed 23 January 2026
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 423 January 2026Stock Option (Right to Buy) · traded 21 January 2026 · filed 23 January 2026
- ▼ sold on the open market 3,749 shares of Palvella TherapeuticsSEC Form 423 January 2026Common Stock · traded 21 January 2026 · filed 23 January 2026
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 423 January 2026Stock Option (Right to Buy) · traded 21 January 2026 · filed 23 January 2026
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 423 January 2026Stock Option (Right to Buy) · traded 21 January 2026 · filed 23 January 2026
- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 423 January 2026Common Stock · traded 21 January 2026 · filed 23 January 2026
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 423 January 2026Common Stock · traded 21 January 2026 · filed 23 January 2026
- ▼ sold on the open market 553 shares of Palvella TherapeuticsSEC Form 423 January 2026Common Stock · traded 21 January 2026 · filed 23 January 2026
- ▼ sold on the open market 3,749 shares of Palvella TherapeuticsSEC Form 423 January 2026Common Stock · traded 21 January 2026 · filed 23 January 2026
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 419 December 2025Stock Option (Right to Buy) · traded 17 December 2025 · filed 19 December 2025
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 419 December 2025Stock Option (Right to Buy) · traded 17 December 2025 · filed 19 December 2025
- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 419 December 2025Common Stock · traded 17 December 2025 · filed 19 December 2025
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 419 December 2025Common Stock · traded 17 December 2025 · filed 19 December 2025
- ▼ sold on the open market 4,302 shares of Palvella TherapeuticsSEC Form 419 December 2025Common Stock · traded 17 December 2025 · filed 19 December 2025
- exercised options over 2,154 shares of Palvella Therapeutics (a derivative holding)SEC Form 421 November 2025Stock Option (Right to Buy) · traded 19 November 2025 · filed 21 November 2025
- exercised options over 2,148 shares of Palvella Therapeutics (a derivative holding)SEC Form 421 November 2025Stock Option (Right to Buy) · traded 19 November 2025 · filed 21 November 2025
- exercised options over 2,154 shares of Palvella TherapeuticsSEC Form 421 November 2025Common Stock · traded 19 November 2025 · filed 21 November 2025
- exercised options over 2,148 shares of Palvella TherapeuticsSEC Form 421 November 2025Common Stock · traded 19 November 2025 · filed 21 November 2025
- ▼ sold on the open market 1,500 shares of Palvella TherapeuticsSEC Form 421 November 2025Common Stock · traded 19 November 2025 · filed 21 November 2025
- ▼ sold on the open market 2,802 shares of Palvella TherapeuticsSEC Form 421 November 2025Common Stock · traded 19 November 2025 · filed 21 November 2025
- was granted 5,373 shares of Palvella Therapeutics (a derivative holding)SEC Form 410 February 2025Incentive Stock Option (right to buy) · traded 5 February 2025 · filed 10 February 2025
- was granted 123,559 shares of Palvella Therapeutics (a derivative holding)SEC Form 410 February 2025Non-Qualified Stock Option (right to buy) · traded 5 February 2025 · filed 10 February 2025
- was granted 27,843 shares of Palvella Therapeutics (a derivative holding)SEC Form 417 December 2024Stock Option (right to buy) · traded 13 December 2024 · filed 17 December 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.